Phase II open-label study of weekly taxoprexin (TXP) as first-line treatment in patients with metastatic cutaneous and mucosal malignant melanoma
In: Journal of Clinical Oncology, Jg. 26 (2008-05-20), S. 9056-9056
Online
unknown
Zugriff:
9056 Background: Taxoprexin (TXP) is a covalent conjugate of paclitaxel and the fatty acid docosahexanoic acid. Due to its unique pharmacokinetics, it can expose melanoma cells to a high concentrat...
Titel: |
Phase II open-label study of weekly taxoprexin (TXP) as first-line treatment in patients with metastatic cutaneous and mucosal malignant melanoma
|
---|---|
Autor/in / Beteiligte Person: | Hwu, W. ; Hwu, P. ; Bedikian, Agop Y. ; Davies, Michael ; Mahoney, Sandy ; Homsi, Jade ; Kim, K. B. ; Papadopoulos, Nicholas E. |
Link: | |
Zeitschrift: | Journal of Clinical Oncology, Jg. 26 (2008-05-20), S. 9056-9056 |
Veröffentlichung: | American Society of Clinical Oncology (ASCO), 2008 |
Medientyp: | unknown |
ISSN: | 1527-7755 (print) ; 0732-183X (print) |
DOI: | 10.1200/jco.2008.26.15_suppl.9056 |
Schlagwort: |
|
Sonstiges: |
|